Table 2 90-days postoperative complications in both groups

Acute rejection*

 T cell mediated rejection (TCMR)

 Banff grade IB

 Banff grade II A

 Both TCMR and ABMR

7 (7.3%)

5

3

2

2

2 (1.8%)

2

2

0

0

0.05

Infection*

 UTI

 CMV

 BKV

 HBV

 HCV

12 (12.5%)

3(3.12%)

2 (2.0%)

3(3.12%)

1(1.04%)

2 (1.8%)

0

1 (0.9%)

0

1(0.9%)

0.002

0.1

0.4

0.1

0.9

New onset diabetes **

13(13.5%)

9 (8.3%)

0.2

Surgical site infection (SSI) *

8 (8.33%)

2 (1.85%)

0.03

Hematoma **

11 (11.45%)

8 (7.4%)

0.3

Lymphocele **

18 (18.75%)

7 (6.48%)

0.007

Incisional Hernia *

3 (3.12%)

1 (0.92%)

0.2

Postoperative urine leak *

1(1%)

0

0.2